The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Alive

Total Raised


Last Raised

$5.03M | 7 mos ago

About APLYiD

APLYiD is a trusted & accredited digital ID solution designed to streamline its users' customer onboarding experience. APLYID brings to the market a SaaS solution that provides a simple, straight-through biometric ID match and checks service that complies with regulatory legislation.

APLYiD Headquarter Location

2B, 22 Pollen Street

Auckland, 1021,

New Zealand

+64 0800969300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest APLYiD News

Our investment in APLYiD

Nov 18, 2021

Find out why we backed APLYiD, a reg-tech startup building a scalable solution to AML and KYC processes.

APLYiD Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo


  • When was APLYiD founded?

    APLYiD was founded in 2018.

  • Where is APLYiD's headquarters?

    APLYiD's headquarters is located at 2B, 22 Pollen Street, Auckland.

  • What is APLYiD's latest funding round?

    APLYiD's latest funding round is Series A.

  • How much did APLYiD raise?

    APLYiD raised a total of $5.03M.

  • Who are the investors of APLYiD?

    Investors of APLYiD include Octopus Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.